Vương quốc Anh - Tiếng Anh - HMA (Heads of Medicines Agencies)

laboratorios syva sa - ceftiofur hydrochloride 50 mg/ml - suspension for injection - cattle, pigs - ceftiofur

Đức - Tiếng Anh - HMA (Heads of Medicines Agencies)

laboratorios syva sa - ceftiofur hydrochloride 50 mg/ml - suspension for injection - cattle, pigs - ceftiofur

Tây Ban Nha - Tiếng Anh - HMA (Heads of Medicines Agencies)

laboratorios syva sa - ceftiofur hydrochloride 50 mg/ml - suspension for injection - cattle, pigs - ceftiofur

Pháp - Tiếng Anh - HMA (Heads of Medicines Agencies)

laboratorios syva sa - ceftiofur hydrochloride 50 mg/ml - suspension for injection - cattle, pigs - ceftiofur

Hungari - Tiếng Anh - HMA (Heads of Medicines Agencies)

laboratorios syva sa - ceftiofur hydrochloride 50 mg/ml - suspension for injection - cattle, pigs - ceftiofur

Ý - Tiếng Anh - HMA (Heads of Medicines Agencies)

laboratorios syva sa - ceftiofur hydrochloride 50 mg/ml - suspension for injection - cattle, pigs - ceftiofur

Hà Lan - Tiếng Anh - HMA (Heads of Medicines Agencies)

laboratorios syva sa - ceftiofur hydrochloride 50 mg/ml - suspension for injection - cattle, pigs - ceftiofur

Bồ Đào Nha - Tiếng Anh - HMA (Heads of Medicines Agencies)

laboratorios syva sa - ceftiofur hydrochloride 50 mg/ml - suspension for injection - cattle, pigs - ceftiofur

Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

biotronik australia pty ltd - 47270 - biventricular pacemaker/defibrillator - a triple chamber rate adaptive icd, with is4 port connecting a quadripolar lv lead, home monitoring functions, max. shock of 40j and df4/is4/is-1 connector. biocompatible titanium housing is hermetically sealed and serves as a potential antipole during shock delivery or in the case of unipolar lead configuration. ellipsoid shape facilitates implanting in the pectoral muscle area. connections for bipolar pacing, sensing, unipolar connections and shock delivery are in the header. mr conditional. rivacor 7 hf-t qp belongs to a family of implantable cardioverter-defibrillators (icds). the primary objective of the therapy is to prevent sudden cardiac death. furthermore, the device is capable of treating bradycardia arrhythmias and cardiac resynchronization therapy with multisite ventricular pacing. the implantation of an icd is a symptomatic therapy with the following objectives: ?termination of spontaneous ventricular fibrillation (vf) through shock delivery ?termination of spontaneous ventricular tachycardia (vt